Methods for making a supported graft

Information

  • Patent Grant
  • 8647458
  • Patent Number
    8,647,458
  • Date Filed
    Friday, December 14, 2012
    12 years ago
  • Date Issued
    Tuesday, February 11, 2014
    10 years ago
Abstract
A method for preparing a stent-graft for intraluminal delivery, including positioning an expanded polytetrafluoroethylene (ePTFE) substrate over a support mandrel, coupling a shape memory member to a polymer cladding to form a polymer clad member, winding the polymer clad member in an overlapping helical manner onto a surface of the ePTFE substrate, joining and sealing adjacent overlapping regions of the polymer clad member together and to the surface of the ePTFE substrate to form a stent-graft, manipulating the stent-graft from a larger first diameter to a smaller second diameter, and loading the stent-graft into a restraining sheath at the smaller second diameter.
Description
BACKGROUND OF THE INVENTION

The present invention relates generally to implantable intraluminal devices, particularly intraluminal grafts. Intraluminal stents are implanted in order to maintain luminal patency, typically after interventional methods have been employed to restore luminal patency from a diseased state, exclude an aneurysmal condition, bypass an occluded or obstructed anatomical region or to shunt body fluids. Surgically implantable prosthetics, particularly vascular prostheses, have been employed for many years. Expanded polytetrafluoroethylene (ePTFE) vascular grafts have been used as biocompatible implants for many years and the use of ePTFE as a bio-inert barrier material in intraluminal applications is well documented. Conventional ePTFE vascular grafts, however, typically lack sufficient diametric mechanical rigidity to maintain luminal patency in intraluminal applications.


Conventional externally supported ePTFE vascular grafts, such as the IMPRA Flex-Graft or the Gore Ring Graft, have an external beading of helically wound non-expanded or solid polytetrafluoroethylene, or of solid fluorinated ethylene-propylene co-polymer (FEP). Non-expanded or solid polytetrafluoroethylene is significantly more rigid than the ePTFE material due to its higher density and absence of interstitial voids. These externally supported ePTFE vascular grafts are not well-suited to interventional intraluminal procedures due to their inability to assume a reduced profile suitable for percutaneous delivery using a catheter and their inability to recover an enlarged diametric dimension in vivo.


Most intraluminal stents are formed of an open lattice fashioned either to be elastically deformable, such as in the case of self-expanding stainless steel spring stents, plastically deformable, such as in the case of balloon-expandable stainless steel PALMAZ stents, or thermally expandable such as by employing shape memory properties of the material used to form the stent. A common problem of most conventional intraluminal stents is re-occlusion of the vessel after stent placement. Tissue ingrowth and neointimal hyperplasia significantly reduces the open diameter of the treated lumen over time, requiring additional therapies.


The present invention makes advantageous use of the known biocompatible and material properties of ePTFE vascular grafts, and adds an abluminal supporting structure capable of being diametrically reduced to an intraluminal delivery profile and self-expanding in vivo to conform to the anatomical topography at the site of intraluminal implantation. More particularly, the present invention consists of an ePTFE substrate material, such as that described in U.S. application Ser. No. 08/794,871, filed Feb. 5, 1997, now U.S. Pat. No. 6,039,755, as a carrier for a helically wound, open cylindrical support structure made of a shape memory alloy.


The inventive intraluminal stent-graft device may be implanted either by percutaneous delivery using an appropriate delivery system, a cut-down procedure in which a surgical incision is made and the intraluminal device implanted through the surgical incision, or by laparoscopic or endoscopic delivery.


Shape memory alloys are a group of metal alloys which are characterized by an ability to return to a defined shape or size when subjected to certain thermal or stress conditions. Shape memory alloys are generally capable of being plastically deformed at a relatively low temperature and, upon exposure to a relatively higher temperature, return to the defined shape or size prior to the deformation. Shape memory alloys may be further defined as one that yields a thermoelastic martensite. A shape memory alloy which yields a thermoelastic martensite undergoes a martensitic transformation of a type that permits the alloy to be deformed by a twinning mechanism below the martensitic transformation temperature. The deformation is then reversed when the twinned structure reverts upon heating to the parent austenite phase. The austenite phase occurs when the material is at a low strain state and occurs at a given temperature. The martensite phase may be either temperature induced martensite (TIM) or stress-induced martensite (SIM).


When a shape memory material is stressed at a temperature above the start of martensite formation, denoted Ms, where the austenitic state is initially stable, but below the maximum temperature at which martensite formation can occur, denoted Md, the material first deforms elastically and when a critical stress is reached, it begins to transform by the formation of stress-induced martensite. Depending upon whether the temperature is above or below the start of austenite formation, denoted As, the behavior when the deforming stress is released differs. If the temperature is below As, the stress-induced martensite is stable, however, if the temperature is above As, the martensite is unstable and transforms back to austenite, with the sample returning to its original shape. U.S. Pat. Nos. 5,597,378, 5,067,957 and 4,665,906 disclose devices, including endoluminal stents, which are delivered in the stress-induced martensite phase of shape memory alloy and return to their pre-programmed shape by removal of the stress and transformation from stress-induced martensite to austenite.


Shape memory characteristics may be imparted to a shape memory alloy by heating the metal at a temperature above which the transformation from the martensite phase to the austenite phase is complete, i.e., a temperature above which the austenite phase is stable. The shape imparted to the metal during this heat treatment is the shape “remembered.” The heat treated metal is cooled to a temperature at which the martensite phase is stable, causing the austenite phase to transform to the martensite phase. The metal in the martensite phase is then plastically deformed, e.g., to facilitate its delivery into a patient's body. Subsequent heating of the deformed martensite phase to a temperature above the martensite to austenite transformation temperature, e.g., body temperature, causes the deformed martensite phase to transform to the austenite phase and during this phase transformation the metal reverts back to its original shape.


The term “shape memory” is used in the art to describe the property of an elastic material to recover a pre-programmed shape after deformation of a shape memory alloy in its martensitic phase and exposing the alloy to a temperature excursion through its austenite transformation temperature, at which temperature the alloy begins to revert to the austenite phase and recover its preprogrammed shape. The term “pseudoelasticity” is used to describe a property of shape memory alloys where the alloy is stressed at a temperature above the transformation temperature of the alloy and stress-induced martensite is formed above the normal martensite formation temperature. Because it has been formed above its normal temperature, stress-induced martensite reverts immediately to undeformed austenite as soon as the stress is removed provided the temperature remains above the transformation temperature.


The present invention employs a wire member made of either a shape memory alloy, preferably a nickel-titanium alloy known as NITINOL, spring stainless steel or other elastic metal or plastic alloys, or composite material, such as carbon fiber. It is preferable that the wire member have either a generally circular, semi-circular, triangular or quadrilateral transverse cross-sectional profile. Where a shape memory alloy material is employed, pre-programmed shape memory is imparted to the wire member by helically winding the wire member about a cylindrical programming mandrel having an outer diametric dimension substantially the same, preferably within a tolerance of about +0 to −15%, as the ePTFE substrate and annealing the programming mandrel and the wire member at a temperature and for a time sufficient to impart the desired shape memory to the wire member. After annealing, the wire member is removed from the programming mandrel, straightened and helically wound about the abluminal wall surface of an ePTFE tubular member at a temperature below the As of the shape memory alloy used to form the wire member.


In order to facilitate bonding of the wire member to the ePTFE tubular member, it is preferable that a bonding agent capable of bonding the support wire member to the ePTFE tubular member be used at the interface between the wire member and the ePTFE tubular member. Suitable biocompatible bonding agents may be selected from the group consisting of polytetrafluoroethylene, polyurethane, polyethylene, polypropylene, polyamides, polyimides, polyesters, polypropylenes, polyethylenes, polyfluoroethylenes, silicone fluorinated polyolefins, fluorinated ethylene/propylene copolymer, perfluoroalkoxy fluorocarbon, ethylene/tetrafluoroethylene copolymer, and polyvinylpyrolidone. The bonding agent may constitute an interfacial layer intermediate the wire member and the ePTFE tubular member, or may be a polymeric cladding at least partially concentrically surrounding the wire member.


Where a cladding is provided, the cladding is preferably a polymeric material selected from the group consisting of polytetrafluoroethylene, polyurethane, polyethylene, polypropylene, polyamides, polyimides, polyesters, polypropylenes, polyethylenes, polyfluoroethylenes, silicone fluorinated polyolefins, fluorinated ethylene/propylene copolymer, perfluoroalkoxy fluorocarbon, ethylene/tetrafluoroethylene copolymer, and polyvinylpyrolidone. The cladding may be either co-extruded with the wire member, extruded as a tube into which the wire member is concentrically inserted after annealing the wire member, or provided as an elongate member which a longitudinal recess which co-axially receives the wire member. Where the bonding agent employed is a melt thermoplastic which has a melt point below the crystalline melt point of polytetrafluoroethylene, the melt thermoplastic bonding agent and the wire member are wound about the ePTFE tubular member, and constrained thereupon, such as by application of circumferential pressure, then the assembly is then exposed to the melt temperatures without longitudinally supporting the assembly.


However, where the bonding agent is polytetrafluoroethylene, bonding of the wire member to the ePTFE tubular member requires exposing the assembly to temperatures above the crystalline melt point of polytetrafluoroethylene in order to effectuate bonding of the wire member to the ePTFE. This is preferably accomplished by introducing the assembly into a sintering oven while the assembly is on a mandrel and the assembly secured to the mandrel by an external helical wrapping of TEFLON tape applied to opposing ends of the assembly to longitudinally constrain the assembly and reduce or eliminate the tendency of the assembly to longitudinally foreshorten during sintering.


BRIEF SUMMARY OF THE INVENTION

It is a primary objective of the present invention to provide a self-supporting, self-expanding stent-graft device which is capable of being delivered to an anatomical position within a human body in a first constrained configuration, positioned in vivo at a desired anatomical site, and the constraint released to permit the stent-graft device to transform to a radially enlarged second configuration.


It is another primary objective of the present invention to provide a stent-graft device which consists generally of tubular member fabricated of a biocompatible polymer selected from the group of microporous expanded polytetrafluoroethylene (“ePTFE”), polyethylene, polyethylene terepthalate, polyurethane and collagen, and at least one winding of a elastically self-expanding wire coupled to either the abluminal or luminal surfaces of the ePTFE tubular member or interdisposed between concentrically positioned ePTFE tubular members.


It is a further objective of the present invention to couple the at least one winding of the elastically self-expanding wire to the ePTFE tubular member by cladding a support wire in a polymeric material which has a melt point less than or equal to that of the ePTFE tubular member and below the A, temperature of the shape memory alloy metal wire.


It is a further objective of the present invention to provide an adhesive interlayer for bonding the shape memory alloy metal wire to the tubular member, the adhesive interlayer being selected from the group consisting of polytetrafluoroethylene, polyurethane, polyethylene, polypropylene, polyamides, polyimides, polyesters, polypropylenes, polyethylenes, polyfluoroethylenes, silicone, fluorinated polyolefins, fluorinated ethylene/propylene copolymer, perfluoroalkoxy fluorocarbon, ethylene/tetrafluoroethylene copolymer, and polyvinylpyrolidone.


It is another objective of the present invention to provide a method for making a—expanding stent-graft device comprised generally of an ePTFE tubular member and at least one winding of a shape memory alloy metal wire coupled to the abluminal surface of the ePTFE tubular member.


These and other objects, features and advantages of the present invention will be better understood by those of ordinary skill in the art from the following more detailed description of the present invention taken with reference to the accompanying drawings and its preferred embodiments.





BRIEF DESCRIPTION OF THE DRAWINGS


FIG. 1 is a side elevational view of a supported intraluminal graft in accordance with a preferred embodiment of the present invention.



FIG. 2 is a cross-sectional view taken along line 2-2 of FIG. 1.



FIG. 3 is a cross-sectional view taken along line 3-3 of FIG. 1.



FIG. 4A is a side elevational cross-sectional view of a graft member mounted onto a mandrel in accordance with a preferred embodiment of the method of the present invention.



FIG. 4B is a side elevational cross-sectional view of FIG. 4A with a support member wrapped about an abluminal surface of the graft member.



FIG. 4C is a side elevational cross-sectional view as in FIGS. 4A and 4B illustrating an abluminal covering concentrically superimposed over they support member and the graft member.



FIG. 5 is a perspective view of a ribbon member clad in a polymeric covering in accordance with the present invention.



FIG. 6 is a cross-sectional view taken along line 6-6 of FIG. 5.



FIG. 7 is a perspective view of a wire member clad in a polymeric covering in accordance with the present invention.



FIG. 8 is a cross-sectional view taken along line 8-8 of FIG. 7.



FIG. 9 is a diagrammatic cross-sectional view of a first embodiment of a support member encapsulated in a shaped polymeric cladding covering.



FIG. 10 is a diagrammatic cross-sectional view of a second embodiment of a support member encapsulated in a shaped polymeric cladding covering.



FIG. 11 is a diagrammatic cross-sectional view of a third embodiment of a support member encapsulated in a shaped polymeric cladding covering.



FIG. 12 is a diagrammatic cross-sectional view of a fourth embodiment of a support member coupled to a shaped polymeric cladding covering.



FIG. 13 is a perspective view of an alternative preferred embodiment of the supported intraluminal graft in accordance with the present invention.



FIG. 14 is a cross-sectional view taken along line 14-14 of FIG. 13.



FIG. 15 is a process flow diagram illustrating the process steps for making the supported intraluminal graft in accordance with the method of the present invention.





DETAILED DESCRIPTION OF THE INVENTION

The shape memory alloy supported intraluminal graft 10 of the present invention consists generally of a tubular substrate 12 having a central lumen 13 passing through an entire longitudinal extent of the tubular substrate. The tubular substrate 12 has a luminal wall surface 15 adjacent the central lumen 13 and an abluminal wall surface 17 opposing the central lumen 13. A support member 14 is provided and is preferably at least partially covered by a polymeric cladding 11. The polymeric clad support member 14 is circumferentially disposed about and joined to the abluminal wall surface 17 of the tubular substrate 12, such as by helically winding the polymeric clad support member 14 about the abluminal surface 17 of the tubular substrate 12. Optionally, a second tubular substrate 19, having an inner diameter sufficiently dimensioned to be concentrically engaged about the abluminal wall surface 17 of the tubular substrate 12 and the polymeric clad support member 14, may be provided.


In accordance with a first preferred embodiment of the present invention, and with particular reference to FIGS. 1-3, there is provided the inventive supported intraluminal graft 10 comprised of a tubular 12 made of a biocompatible polymeric material, such as expanded polytetrafluoroethylene (“ePTFE”), polyethylene terepthalate (“PET”) such as that marketed and sold under the trademark DACRON, polyethylene, or polyurethane. Expanded PTFE substrate materials are preferably made by ram extruding an admixture of polytetrafluoroethylene resin and a hydrocarbon lubricant to form a tubular extrudate, drying off the hydrocarbon lubricant, longitudinally expanding the dried tubular extrudate, then sintering the longitudinally expanded dried tubular extrudate at a temperature above the crystalline melt point of polytetrafluoroethylene.


The resulting tubular ePTFE material has a microporous microstructure which is composed of spaced-apart nodes interconnected by fibrils, with the fibrils being oriented parallel to the longitudinal axis of the ePTFE tube and parallel to the axis of longitudinal expansion. U.S. Pat. Nos. '390 and '566, both issued to Gore, teach processes for making ePTFE tubular substrates and are hereby incorporated by reference as teaching processes to make ePTFE tubular and planar materials. A tubular substrate may also be made by weaving yarn, made of either polyester or ePTFE, into a tubular structure as is well known in the art. Additionally, the tubular substrate 12 may have a cylindrical profile having a substantially uniform internal diameter along its longitudinal axis, or may have a tapered sidewall in which the tubular substrate 12 assumes a generally frustroconical shape in which the internal diameter of the tubular substrate 12 increases or deceases along the longitudinal axis of the tubular substrate 12. Alternatively, the tubular substrate 12 may have at least one region of stepped diameter in which the internal diameter of the tubular substrate changes at a discrete longitudinal section of the tubular substrate 12.


In accordance with a first preferred embodiment of the present invention, the tubular substrate 12 is an extruded, longitudinally expanded and sintered ePTFE tubular member which has been radially expanded from an initial luminal inner diameter of between about 1.5 mm to about 6 mm to a final luminal inner diameter of between about 3 mm to about 18 mm. Thus, tubular substrate 12 is initially fabricated at a first relatively smaller diametric dimension, dried of the hydrocarbon lubricant, and sintered, then radially expanded by application of an radially outwardly directed force applied to the luminal wall surface 15 of the tubular substrate 12, which radially deforms the wall of the tubular substrate 12 from an initial luminal inner diameter, denoted D1, to a second, enlarged luminal inner diameter, denoted D2. Alternatively, tubular substrate 12 may be provided as an extruded, longitudinally expanded and sintered ePTFE tubular member having an inner diameter equivalent to the final inner diameter of the supported intraluminal graft, e.g., extruded to a luminal diameter of between about 3 mm to about 18 mm, and a wall thickness sufficient to acceptably minimize the delivery profile of the supported intraluminal graft. Suitable wall thicknesses for the non-radially expanded ePTFE tubular member are considered less than or equal to about 0.3 mm for delivery to peripheral anatomic passageways.


The tubular substrate 12 is preferably radially expanded by loading the tubular substrate 12, in its fully or partially sintered state, onto an inflation balloon such that the tubular substrate 12 is concentrically engaged upon the inflation balloon, introducing the inflation balloon and tubular substrate 12 into a tubular housing defining a generally cylindrical cavity having an inner diameter corresponding to the maximum desired outer diameter of the final shape memory alloy supported graft, and applying a fluid pressure to the inflation balloon to inflate the inflation balloon and radially deform the tubular substrate 12 into intimate contact with the generally cylindrical cavity. Pressure is maintained within the inflation balloon for a period of time sufficient to minimize the inherent recoil property of the ePTFE material in the tubular substrate 12, then the pressure is relieved and the inflation balloon permitted to deflate. The radially deformed tubular substrate, now having an inner luminal diameter D2, is removed from the generally cylindrical cavity for subsequent processing.


During radial expansion of the tubular substrate 12 from D1 to D2, the node and fibril microstructure of the ePTFE tubular substrate is deformed. The nodes, which have an orientation perpendicular to the longitudinal axis of the tubular substrate 12 and parallel to the radial axis of the tubular substrate 12, deform along the longitudinal axis of each node to form elongated columnar structures, while the length of the fibrils interconnecting adjacent pairs of nodes in the longitudinal axis of the tubular substrate 12, remains substantially constant. The fibril length is also referred to herein as the “internodal distance.”


A support member 14, which is preferably made of an elastic wire material selected from the group of thermoelastic or shape memory alloys, spring stainless steel, elastic metal or plastic alloys, or composite materials, such as woven carbon fibers. Where a shape memory alloy is employed, it is important that the shape memory alloy have a transition temperature below human body temperature, i.e., 37 degrees Celsius, to enable the shape memory alloy to undergo transformation to the austenite phase when the shape memory alloy wire member is exposed to human body temperature in vivo. In accordance with the best mode currently known for the present invention, the preferred shape memory alloy is a near equiatomic alloy of nickel and titanium.


To facilitate attachment of the elastic or thermoelastic wire member 14 to the tubular substrate 12, it is contemplated that a polymeric cladding 11 be provided to at least partially cover the support wire member 14 and facilitate adhesion between the support wire member 14 and the abluminal wall surface 17 of the tubular substrate 12. In accordance with the best mode for practicing the present invention, it is preferable that the polymeric cladding 11 be selected from the group of biocompatible polymeric materials consisting of polytetrafluoroethylene, polyurethane, polyethylene, polypropylene, polyamides, polyimides, polyesters, polypropylenes, polyethylenes, polyfluoroethylenes, silicone, fluorinated polyolefins, fluorinated ethylene/propylene copolymer, perfluoroalkoxy fluorocarbon, ethylene/tetrafluoroethylene copolymer, and polyvinylpyrolidone.


As will hereinafter be described more fully, the polymeric cladding 11 may be coupled to the support wire member 14 by any of a variety of known methodologies. For example, the polymeric cladding 11 may be co-extruded with the support wire member 14, the polymeric cladding 11 may be extruded with an opening passing through the polymeric cladding 11 along its longitudinal axis and dimensioned to receive the support wire member 14 there through, the polymeric cladding 11 may have a longitudinally extending recess dimensioned to receive and retain the support wire member 14 therein, or the polymeric cladding 11 may be applied onto the support wire member 11 in dispersion form, such as by dipcoating or spraying, and the solvent or aqueous vehicle dried thereby forming a covering on the support wire member 11.


The support wire member 14 in its polymeric cladding 11 is circumferentially joined to the abluminal wall surface 17 of the tubular substrate 12, such as by helically winding at least one length of polymeric clad support wire member 14 in a regular or irregular helical pattern, or by applying the polymeric clad support wire member 14 as a series of spaced-apart circumferential rings, along at least a portion of the longitudinal axis of the abluminal wall surface 17 of the tubular substrate 12. It is preferable that the tubular substrate 12 be mounted onto a supporting mandrel [not shown] having an outer diameter closely toleranced to the inner diameter of the tubular substrate 12 to permit the tubular substrate 12 to be placed thereupon and secured thereto without deforming the tubular substrate 12.


A second tubular member 19 may, optionally, be concentrically engaged about the tubular member 12 and the polymeric clad support wire member 14. As more clearly depicted in FIGS. 2-3, where the second tubular member 19 is employed and disposed circumferentially about the tubular member 12 and the polymeric clad support wire member 14, the tubular member 12 and the second tubular member 19 encapsulate the polymeric clad support wire member 14. Where the tubular member 12 and the second tubular member 19 are both made of longitudinally expanded ePTFE, each will have a microporous microstructure in which the fibrils are oriented parallel to the longitudinal axis of each of the tubular member 12 and the second tubular member 19, throughout their respective wall thicknesses. The encapsulation of the polymeric clad support wire member 14 is best accomplished by providing both the tubular member 12 and the second tubular member 19 as unsintered or partially sintered tubes.


After wrapping the polymeric clad support wire member 14 about the abluminal surface of the tubular member 12, and circumferentially engaging the second tubular member 19 thereabout, it is preferable to apply a circumferential pressure to the assembly, while the assembly is on the supporting mandrel [not shown]. Circumferential pressure may be applied to the assembly by, for example, helically wrapping tetrafluoroethylene film tape about the abluminal surface of the second tubular member 19 along its longitudinal axis, or by securing opposing ends of the assembly on the supporting mandrel, and rolling the assembly to calendar the assembly. After the circumferential pressure is applied to the assembly, the assembly is then introduced into either a convention or radiant heating oven, set at a temperature above the melt point of the material used to fabricate the tubular member 12, the second tubular member 19 and/or the polymeric cladding 11, for a period of time sufficient to bond the tubular member 12, the second tubular member 19 and the polymeric cladding 11 into a substantially monolithic, unitary structure. Where polytetrafluoroethylene is used, it has been found that it is preferable to heat the assembly in a radiant heating oven.



FIGS. 4A-4C depict the method steps for making the inventive shape memory alloy supported intraluminal graft 10. With a first step 20, tubular member 12 is concentrically engaged onto a supporting mandrel 22 such that the supporting mandrel 22 resides within the lumen of the tubular member 12. A helical winding of polymeric clad support wire member 14 is applied about the abluminal wall surface 17 of the tubular member 12 at step 25. The helical windings have an interwinding distance 27 which is preferably at least one times the distance 29 which represents the width of the polymer cladding 11, in the case of a planar polymer cladding 11, or the diameter, in the case of a tubular polymer cladding 11 having a circular transverse cross-section.


The helical winding of the polymeric clad support wire member 14 contacts the abluminal wall surface 17 of the tubular member 12 at an interfacial region 28. According to one preferred embodiment of the present invention there is provided an adhesive material 23 selected from the group consisting of polytetrafluoroethylene, polyurethane, polyethylene, polypropylene, polyamides, polyimides, polyesters, polypropylenes, polyethylenes, polyfluoroethylenes, silicone, fluorinated polyolefins, fluorinated ethylene/propylene copolymer, perfluoroalkoxy fluorocarbon, ethylene/tetrafluoroethylene copolymer, and polyvinylpyrolidone. The adhesive material is preferably applied to the interfacial region 28 of the polymeric clad support wire member 14, but may also be applied in a pattern directly to a surface of the tubular substrate and the SMA wire member 14 brought into contact with the adhesive material. In this manner, as the polymeric clad support wire member 28 is helically applied to the abluminal wall surface 17 of the tubular member 12, the adhesive material 23 forms an interlayer intermediate the polymeric clad support wire member 28 and the abluminal wall surface 17 of the tubular member 12.


Where the selected adhesive material 23 has a melt point less than the crystalline melt point of polytetrafluoroethylene, i.e., about 327 degrees Centigrade, the resulting assembly of step 25 may be introduced into a heating oven set at the melt temperature of the selected adhesive material 23, for a period of time sufficient to melt the adhesive material 23 and impart an adhesive bond between the polymeric clad support wire member 14 and the tubular member 12. On the other hand, where the selected adhesive material 23 is polytetrafluoroethylene, an external covering of a second tubular member 26 may be concentrically engaged about the assembly resulting from step 25, a circumferential pressure exerted to the second tubular member 26, thereby bringing the second tubular member 26, the polymer clad support wire member 11 and the tubular member 12 into intimate contact with one another, and the entire assembly introduced into a sintering oven set at a temperature above the crystalline melt point of polytetrafluoroethylene and for a period of time sufficient to meld the second tubular member 26 and the tubular member 12 to one another to form a resultant substantially monolithic structure which is substantially devoid of interfacial demarcations between the second tubular member 26 and the tubular member 12, with the polymer clad support wire member 14 residing intermediate there between.


Turning now to FIGS. 5-12, there is depicted numerous alternate configurations of the polymer clad support wire member 14. FIGS. 5 and 6 depict a first embodiment of the polymer clad support wire member 34 in which the support wire member is formed as a planar ribbon wire 38 having a generally tubular box-like polymer cladding 36 provided about the outer surfaces of the planar ribbon wire 38. In the transverse cross-sectional view of FIG. 6 it will be seen that both the planar ribbon wire 38 and the polymer cladding 36 have generally quadrilateral cross-sectional configurations.



FIGS. 7-8 depict a second embodiment of the polymer clad support wire member 40 in which the support wire member is formed as a cylindrical wire 44 having a generally tubular polymer cladding 42 provided about the outer circumference of the planar ribbon wire 44. In the transverse cross-sectional view of FIG. 8 it will be seen that both the cylindrical wire 44 and the polymer cladding 42 have generally circular cross-sectional configurations.



FIGS. 9-12 are provided in the transverse cross-sectional views only, it being understood that like FIGS. 5 and 7, each of the embodiments depicted in FIGS. 9-12 have corresponding perspective configurations. FIG. 9 depicts a third embodiment of the polymer clad support wire member 46 in which the support wire member is formed as a cylindrical wire having a generally triangular-shaped polymer cladding 48, with a central longitudinal cylindrical bore to accommodate the cylindrical wire 49 therein, which is provided about the outer surfaces of the cylindrical wire 49. A fourth embodiment of the polymer clad support wire member 50 is depicted in FIG. 10. Polymer clad support wire member 50 consists generally of a polymer cladding 52 having a plurality of planar surfaces and having a generally quadrilateral transverse cross-sectional shape, while the support wire member 54 is generally cylindrical with a generally circular transverse cross-section.


As depicted in FIG. 11, a fifth embodiment of the polymer clad support wire member 60 is depicted. Here, the support wire member 54 has a generally cylindrical shape with a generally circular transverse cross-section, while the polymer cladding 62 has a main body portion having a generally circular transverse cross-section, but has additional projections extending radially outward from the generally circular main body portion to increase the bonding surface area of the polymer clad support wire member 60. Finally, as depicted in FIG. 12, the sixth embodiment of the polymer clad support wire member 70 is depicted. In accordance with this sixth embodiment there is provided a generally cylindrical support wire member 76 having a generally circular transverse cross-section, while the polymer cladding 72 is provided with a generally triangular cross-sectional shape, with hemispherical recess 74 formed in an apex of the generally triangular cross-sectional shape. The hemispherical recess 74 subtends at least a 180 degree arc and extends along a substantial longitudinal extent of the polymer cladding 72. The generally cylindrical support wire member 76 is engaged in the hemispherical recess 74 and retained therein by an interference fit, or by other suitable means, such as an adhesive.


It will be understood by those skilled in the art, that each of the foregoing embodiments of the polymer clad support wire member may be made by pulltrusion methods in which the shape memory alloy wire member, having a pre-programmed austenite phase, is fed into an extruder during extrusion of the polymer cladding, or by extruding the polymer cladding with a central lumen, dimensioned appropriately to permit engagement of the shape memory alloy wire, then threading the support wire member into the central lumen of the polymer cladding.


Finally, an alternative embodiment of a shape memory alloy supported intraluminal graft 80 is depicted in FIGS. 13 and 14. The inventive shape memory alloy supported intraluminal graft 80 may be formed by helically wrapping a length of polymer clad 84 shape memory alloy wire 86 about a supporting winding mandrel, such that the polymer cladding 84 has overlapping regions 88 which form seams. The resulting assembly is then heated above the melt point of the polymer cladding 84 to join and seal the overlapping regions 88 to one another.


The inventive method 100 for making the inventive wire supported intraluminal graft, described above, is illustrated with reference to FIG. 15. An elastic or thermoelastic wire member is provided at step 102 along with a shaping mandrel 104. The shaping mandrel 104 is preferably a solid cylindrical or tubular cylindrical stainless steel member capable of withstanding annealing temperatures of shape memory alloys. At step 106, the wire member provided at step 102 is wound onto the shaping mandrel provided at step 104. The wire member is preferably helically wound about the shaping mandrel such that adjacent windings are substantially uniformly spaced from one another. It is also contemplated that the wire member may be wound about the shaping mandrel in any of a wide number of configurations, including non-uniformly spaced windings long portions of the shaping mandrel, such that certain regions of the winding have higher and lower frequency windings than other regions, that the winding be shaped as adjacent circumferential loops such as that shape disclosed in Gianturco, U.S. Pat. No. 4,907,336 or Wiktor, U.S. Pat. No. 4,969,458, both hereby incorporated by reference as teaching a shape of winding suitable for use with the present invention, or virtually any other shape which is capable for forming an open tubular structural skeleton, including, without limitation, a helical winding having a plurality of sinusoidal bends along a length thereof, as taught by Wiktor, U.S. Pat. No. 4,886,062 or Pinchuck, U.S. Pat. No. 5,019,090, both hereby incorporated by reference as teaching alternative configurations of helical windings of wire members.


Where a thermoelastic shape memory alloy (SMA) wire member is utilized, the SMA wire member is wound about the shaping mandrel, the shape of the wound SMA wire member is programmed at step 108 by annealing the SMA wire member at a temperature and for a time sufficient to impart shape memory properties to the SMA wire member. At step 110, the preprogrammed SMA alloy wire member is then exposed to temperature conditions below the Mf temperature of the SMA alloy. While it is maintained below the Mf temperature of the SMA alloy, the wire member is removed from the shaping mandrel and straightened to a linear shape at step 112. If the SMA alloy wire member is to be covered with a cladding, a polymeric tubular cladding is provided at step 118 and the SMA alloy wire member is threaded into the lumen of the tubular cladding at step 120.


It is preferable that steps 118 and 120 be performed while the SMA alloy wire member is maintained at a temperature below the Mf temperature of the SMA alloy to prevent shape recovery of the SMA alloy wire member. Alternatively, if no polymeric cladding is to be employed, but the SMA alloy wire member from step 112 is to be adhered, an adhesive material may be applied to the SMA alloy wire member at step 122. Step 122 may be conducted while the SMA alloy wire member is at a temperature below the Mf temperature, however, due to the fact that most adhesives may not adhere to the SMA alloy wire member at such temperatures, the adhesive is preferably applied to the SMA alloy wire member while it is in the austenite state. Where an elastic wire member, such as a support structure made from stainless steel spring wire, is employed, the shape programming described in the preceding paragraph may, of course, be omitted.


After application of the polymeric cladding at steps 118 and 120, or after the adhesive is applied at step 122, or where step 122 is conducted at a temperature below the Mf temperature of the SMA alloy, the SMA wire is then exposed to a temperature excursion to above the Af temperature of the SMA alloy at step 114 so that the SMA alloy wire member recovers its programmed shape at step 116. Where an elastic wire member is employed, it is not sensitive to temperature excursions and the temperature excursion step may be omitted.


A tubular substrate, made of, for example, extruded ePTFE, preferably extruded ePTFE which has been radially deformed from its nominal extruded diameter to an enlarged diameter, or woven polyester, is provided at step 123. The wire member in its enlarged shape, which in the case of an SMA wire member is its programmed shape, or in the case of an elastic wire member, in its unstressed state, is concentrically engaged about the tubular substrate at step 124, and joined to the tubular substrate at step 126 by thermally bonding the adhesive or the polymeric cladding to the abluminal or luminal surface of the tubular substrate. It is preferable that step 126 be conducted while the tubular substrate is supported by a support mandrel and that the SMA alloy wire member is retained in intimate contact with a surface of the tubular substrate with at least a portion of the wire member. The wire member, either in its clad or unclad state, may be retained in intimate contact against either by tension wrapping the wire member or by an external covering wrap of a release material, such as polytetrafluoroethylene tape, to cover at least a portion of the wire member.


After the wire member is joined to the tubular substrate, the assembly may optionally be sterilized at step 128, such as by exposure to ethylene oxide for a time and under appropriate conditions to sterilize the assembly. Where an SMA alloy wire member is employed, the assembly is then exposed to a temperature below the AS temperature of the SMA alloy wire member at step 130 and the assembly is mechanically deformed to a smaller diametric profile at step 132. Where an elastic wire member is employed, the assembly is mechanically deformed to a smaller diametric profile at step 132 largely independent of temperature conditions. Step 132 may be performed by any suitable means to reduce the diametric profile of the assembly, such as by drawing it through a reducing die, manually manipulating the assembly to a reduced diametric profile, or folding the device.


The reduced profile assembly is then loaded onto a delivery catheter and covered with a restraining sheath at step 134. Once loaded onto a delivery catheter and covered with a restraining sheath to prevent shape recovery. In the case where the wire member is an SMA alloy, loading the assembly onto a delivery catheter and covering with a restraining sheath requires that step 134 be performed at a temperature below the AS temperature of the SMA alloy wire in order to prevent thermoelastic recovery of the SMA alloy wire member. Where, however, the wire member is fabricated of an elastic material, the loading step 134 is not largely temperature sensitive and may be performed at room temperature. While the wire member will exert shape recovery forces at room temperature, e.g., above the AS temperature of the SMA alloy wire employed, the restraining sheath of the delivery catheter will prevent the SMA alloy wire member from recovering its programmed shape and carrying the tubular substrate to the programmed shape of the SMA alloy wire member. Optionally, the sterilization step 128 may also be performed after the assembly is loaded onto the delivery catheter at step 134.


While the present invention has been described with reference to its preferred embodiments and the best mode known to the inventor for making the inventive shape memory alloy supported intraluminal graft, it will be appreciated that variations in material selection for the polymer cladding, for the shape memory alloy, or process variations, such as the manner of winding the polymer clad support wire member about either a winding mandrel or a tubular member, or times and conditions of the manufacturing steps, including material selection, may be made without departing from the scope of the present invention which is intended to be limited only by the appended claims.

Claims
  • 1. A method for preparing a stent-graft for intraluminal delivery, comprising: positioning an expanded polytetrafluoroethylene (ePTFE) substrate over a support mandrel;coupling a shape memory member to a polymer cladding to form a polymer clad member;winding the polymer clad member in an overlapping helical manner onto a surface of the ePTFE substrate;joining and sealing adjacent overlapping regions of the polymer clad member together and to the surface of the ePTFE substrate to form a stent-graft;manipulating the stent-graft from a larger first diameter to a smaller second diameter; andloading the stent-graft into a restraining sheath at the smaller second diameter.
CROSS-REFERENCE TO RELATED APPLICATIONS

This application is a continuation of U.S. patent application Ser. No. 13/434,472, now U.S. Pat. No. 8,337,650, filed Mar. 29, 2012, which is a continuation of U.S. patent application Ser. No. 12/546,483, filed Aug. 24, 2009, now U.S. Pat. No. 7,578,899, which is a continuation of U.S. patent application Ser. No. 11/429,849, filed May 8, 2006, now U.S. Pat. No. 7,578,899, which is a continuation of U.S. patent application Ser. No. 10/431,685, filed May 8, 2003, now U.S. Pat. No. 7,060,150, which is a divisional of U.S. patent application Ser. No. 09/855,918, filed May 15, 2001, now abandoned, which is a divisional of U.S. patent application Ser. No. 08/999,583, filed Dec. 22, 1997, now U.S. Pat. No. 6,264,684, which is a continuation-in-part of three applications: 1) International Application No. PCT/US95/16497, filed Dec. 8, 1995, which was nationalized as U.S. patent application Ser. No. 09/077,533, filed May 28, 1998, now U.S. Pat. No. 6,053,943; 2) U.S. patent application Ser. No. 08/833,797, filed Apr. 9, 1997, now U.S. Pat. No. 6,451,047, which is a continuation-in-part of U.S. patent application Ser. No. 08/508,033, filed Jul. 27, 1995, now U.S. Pat. No. 5,749,880, which is a continuation-in-part of U.S. patent application Ser. No. 08/401,871, filed Mar. 10, 1995, now U.S. Pat. No. 6,124,523; and 3) U.S. patent application Ser. No. 08/794,871, filed Feb. 5, 1997, now U.S. Pat. No. 6,039,755. This application expressly incorporates by reference the entirety of each of the above-mentioned applications as if fully set forth herein.

US Referenced Citations (343)
Number Name Date Kind
612897 Ellis Oct 1898 A
1505591 Goldfarb Feb 1924 A
2642625 Peck Jun 1953 A
3027601 Barry Apr 1962 A
3060517 Fields Oct 1962 A
3105492 Jeckel Oct 1963 A
3196194 Ely, Jr. et al. Jul 1965 A
3207601 Barry Sep 1965 A
3281511 Goldsmith Oct 1966 A
3304557 Polansky Feb 1967 A
3657744 Ersek Apr 1972 A
3767500 Tally et al. Oct 1973 A
3887761 Gore Jun 1975 A
3992725 Homsy Nov 1976 A
4061517 Dutton, III et al. Dec 1977 A
4159370 Koizumi et al. Jun 1979 A
4324574 Fagan Apr 1982 A
RE31341 Koizumi et al. Aug 1983 E
4416028 Eriksson et al. Nov 1983 A
RE31618 Mano et al. Jul 1984 E
4482516 Bowman et al. Nov 1984 A
4503569 Dotter Mar 1985 A
4512338 Balko et al. Apr 1985 A
4580568 Gianturco Apr 1986 A
4588461 Braun May 1986 A
4596837 Yamamoto et al. Jun 1986 A
4604762 Robinson Aug 1986 A
4629458 Pinchuk Dec 1986 A
4647416 Seiler, Jr. et al. Mar 1987 A
4655769 Zachariades Apr 1987 A
4665906 Jervis May 1987 A
4714748 Hoashi et al. Dec 1987 A
4731073 Robinson Mar 1988 A
4733665 Palmaz Mar 1988 A
4739762 Palmaz Apr 1988 A
4747849 Galtier May 1988 A
4760102 Moriyama et al. Jul 1988 A
4767418 Deininger et al. Aug 1988 A
4776337 Palmaz Oct 1988 A
4816339 Tu et al. Mar 1989 A
4820298 Leveen et al. Apr 1989 A
4830062 Yamamoto et al. May 1989 A
4850999 Planck Jul 1989 A
4857069 Kira Aug 1989 A
4886062 Wiktor Dec 1989 A
4907336 Gianturco Mar 1990 A
4922905 Strecker et al. May 1990 A
4935068 Duerig Jun 1990 A
4954126 Wallsten et al. Sep 1990 A
4955899 Della Corna et al. Sep 1990 A
4957669 Primm Sep 1990 A
4969458 Wiktor Nov 1990 A
4969896 Shors Nov 1990 A
5019090 Pinchuk May 1991 A
5061275 Wallsten et al. Oct 1991 A
5061276 Tu et al. Oct 1991 A
5064435 Porter Nov 1991 A
5067957 Jervis Nov 1991 A
5071609 Tu et al. Dec 1991 A
5078726 Kreamer Jan 1992 A
5078736 Behl Jan 1992 A
5084065 Weldon et al. Jan 1992 A
5102417 Palmaz Apr 1992 A
5116360 Pinchuk et al. May 1992 A
5116365 Hillstead May 1992 A
5122154 Rhodes Jun 1992 A
5123917 Lee Jun 1992 A
5124523 Oehlmann et al. Jun 1992 A
5133732 Wiktor Jul 1992 A
5135503 Abrams Aug 1992 A
5139480 Hickle et al. Aug 1992 A
5143085 Wilson Sep 1992 A
5152782 Kowligi et al. Oct 1992 A
5156620 Pigott Oct 1992 A
5158548 Lau et al. Oct 1992 A
5163951 Pinchuk et al. Nov 1992 A
5167614 Tessmann et al. Dec 1992 A
5171805 Tatemoto et al. Dec 1992 A
5192307 Wall Mar 1993 A
5195984 Schatz Mar 1993 A
5211658 Clouse May 1993 A
5219355 Parodi et al. Jun 1993 A
5219361 von Recum et al. Jun 1993 A
5231989 Middleman et al. Aug 1993 A
5234456 Silvestrini Aug 1993 A
5234739 Tanaru et al. Aug 1993 A
5236446 Dumon Aug 1993 A
5236447 Kubo et al. Aug 1993 A
5242399 Lau et al. Sep 1993 A
5258027 Berghaus et al. Nov 1993 A
5282823 Schwartz et al. Feb 1994 A
5282824 Gianturco Feb 1994 A
5282847 Trescony et al. Feb 1994 A
5282848 Schmitt Feb 1994 A
5282849 Kolff et al. Feb 1994 A
5282860 Matsuno et al. Feb 1994 A
5316023 Palmaz et al. May 1994 A
5330500 Song et al. Jul 1994 A
5334201 Cowan Aug 1994 A
5341818 Abrams et al. Aug 1994 A
5344426 Lau et al. Sep 1994 A
5349964 Imran et al. Sep 1994 A
5354309 Schnepp-Pesch et al. Oct 1994 A
5354329 Whalen Oct 1994 A
5360443 Barone et al. Nov 1994 A
5366504 Andersen et al. Nov 1994 A
5370681 Herweck et al. Dec 1994 A
5370691 Samson Dec 1994 A
5376110 Tu et al. Dec 1994 A
5382261 Palmaz Jan 1995 A
5383106 Yoshida et al. Jan 1995 A
5383892 Cardon et al. Jan 1995 A
5383926 Lock et al. Jan 1995 A
5383928 Scott et al. Jan 1995 A
5384019 Keating et al. Jan 1995 A
5385580 Schmitt Jan 1995 A
5387235 Chuter Feb 1995 A
5387236 Noishiki et al. Feb 1995 A
5389106 Tower Feb 1995 A
5395390 Simon et al. Mar 1995 A
5405377 Cragg Apr 1995 A
5405378 Strecker et al. Apr 1995 A
5411476 Abrams et al. May 1995 A
5421955 Lau et al. Jun 1995 A
5429869 McGregor et al. Jul 1995 A
5433996 Kranzler et al. Jul 1995 A
5437083 Williams et al. Aug 1995 A
5443496 Schwartz et al. Aug 1995 A
5449373 Pinchasik et al. Sep 1995 A
5452726 Burmeister et al. Sep 1995 A
5458615 Klemm et al. Oct 1995 A
5464438 Menaker Nov 1995 A
5464440 Johansson et al. Nov 1995 A
5464449 Ryan et al. Nov 1995 A
5474563 Myler et al. Dec 1995 A
5489295 Piplani et al. Feb 1996 A
5496364 Schmitt Mar 1996 A
5500013 Buscemi et al. Mar 1996 A
5507767 Maeda et al. Apr 1996 A
5507768 Lau et al. Apr 1996 A
5507769 Marin et al. Apr 1996 A
5507771 Gianturco Apr 1996 A
5514115 Frantzen et al. May 1996 A
5514154 Lau et al. May 1996 A
5522881 Lentz Jun 1996 A
5522883 Slater et al. Jun 1996 A
5523092 Hanson et al. Jun 1996 A
5527353 Schmitt Jun 1996 A
5527355 Ahn Jun 1996 A
5540712 Kleshinski et al. Jul 1996 A
5540713 Schnepp-Pesch et al. Jul 1996 A
5546646 Williams et al. Aug 1996 A
5549635 Solar Aug 1996 A
5549663 Cottone, Jr. Aug 1996 A
5554181 Das Sep 1996 A
5556389 Liprie Sep 1996 A
5556413 Lam Sep 1996 A
5556414 Turi Sep 1996 A
5556426 Popadiuk et al. Sep 1996 A
5562725 Schmitt et al. Oct 1996 A
5569295 Lam Oct 1996 A
5571170 Palmaz et al. Nov 1996 A
5571171 Barone et al. Nov 1996 A
5571173 Parodi et al. Nov 1996 A
5573520 Schwartz et al. Nov 1996 A
5591197 Orth et al. Jan 1997 A
5591222 Susawa et al. Jan 1997 A
5591223 Lock et al. Jan 1997 A
5591224 Schwartz et al. Jan 1997 A
5591228 Edoga Jan 1997 A
5591229 Parodi et al. Jan 1997 A
5591288 Becker et al. Jan 1997 A
5593417 Rhodes Jan 1997 A
5597378 Jervis Jan 1997 A
5603721 Lau et al. Feb 1997 A
5607445 Summers Mar 1997 A
5607478 Lentz et al. Mar 1997 A
5609624 Kalis Mar 1997 A
5620763 House et al. Apr 1997 A
5628786 Banas et al. May 1997 A
5628788 Pinchuk May 1997 A
5630806 Inagaki et al. May 1997 A
5630829 Lauterjung May 1997 A
5630840 Mayer May 1997 A
5632840 Campbell May 1997 A
5639278 Dereume et al. Jun 1997 A
5645559 Hachtman et al. Jul 1997 A
5649950 Bourne et al. Jul 1997 A
5649977 Campbell Jul 1997 A
5653727 Wiktor Aug 1997 A
5653747 Dereume et al. Aug 1997 A
5665117 Rhodes Sep 1997 A
5667523 Bynon et al. Sep 1997 A
5674241 Bley et al. Oct 1997 A
5674277 Freitag Oct 1997 A
5676671 Inoue et al. Oct 1997 A
5681345 Euteneuer Oct 1997 A
5683448 Cragg Nov 1997 A
5683453 Palmaz Nov 1997 A
5693085 Buirge et al. Dec 1997 A
5693088 Lazarus Dec 1997 A
5700285 Myers et al. Dec 1997 A
5700286 Tartaglia et al. Dec 1997 A
5713949 Jayaraman et al. Feb 1998 A
5716393 Lindenberg et al. Feb 1998 A
5718159 Thompson Feb 1998 A
5718973 Lewis et al. Feb 1998 A
5719873 Yamashita et al. Feb 1998 A
5723003 Winston et al. Mar 1998 A
5723004 Dereume et al. Mar 1998 A
5728131 Frantzen et al. Mar 1998 A
5728158 Lau et al. Mar 1998 A
5735892 Myers et al. Apr 1998 A
5735893 Lau et al. Apr 1998 A
5738674 Williams et al. Apr 1998 A
5749880 Banas et al. May 1998 A
5755770 Ravenscroft May 1998 A
5755774 Pinchuk May 1998 A
5755781 Jayaraman et al. May 1998 A
5766238 Lau et al. Jun 1998 A
5769817 Burgmeier Jun 1998 A
5769884 Solovay Jun 1998 A
5776161 Globerman et al. Jul 1998 A
5782904 White et al. Jul 1998 A
5788626 Thompson Aug 1998 A
5800512 Lentz et al. Sep 1998 A
5810870 Myers et al. Sep 1998 A
5824037 Fogarty et al. Oct 1998 A
5824043 Cottone, Jr. Oct 1998 A
5824046 Smith et al. Oct 1998 A
5824053 Khosravi et al. Oct 1998 A
5824054 Khosravi et al. Oct 1998 A
5843161 Solovay Dec 1998 A
5843166 Lentz et al. Dec 1998 A
5849037 Frid et al. Dec 1998 A
5851232 Lois Dec 1998 A
5863366 Snow Jan 1999 A
5871536 Lazarus Feb 1999 A
5871537 Holman et al. Feb 1999 A
5873906 Lau et al. Feb 1999 A
5876448 Thompson et al. Mar 1999 A
5919225 Lau et al. Jul 1999 A
5925061 Ogi et al. Jul 1999 A
5928279 Shannon et al. Jul 1999 A
5961545 Lentz et al. Oct 1999 A
5968070 Bley et al. Oct 1999 A
5968091 Pinchuk et al. Oct 1999 A
6001125 Golds et al. Dec 1999 A
6004348 Banas et al. Dec 1999 A
6010529 Herweck et al. Jan 2000 A
6010530 Goicoechea Jan 2000 A
6015431 Thornton et al. Jan 2000 A
6036724 Lentz et al. Mar 2000 A
6039755 Edwin et al. Mar 2000 A
6042605 Martin et al. Mar 2000 A
6048484 House et al. Apr 2000 A
6053943 Edwin et al. Apr 2000 A
6063111 Hieshima et al. May 2000 A
6090127 Globerman Jul 2000 A
6120535 McDonald et al. Sep 2000 A
6124523 Banas et al. Sep 2000 A
6139573 Sogard et al. Oct 2000 A
6149681 Houser et al. Nov 2000 A
6156062 McGuinness Dec 2000 A
6165210 Lau et al. Dec 2000 A
6214039 Banas et al. Apr 2001 B1
6264684 Banas et al. Jul 2001 B1
6306141 Jervis Oct 2001 B1
6309343 Lentz et al. Oct 2001 B1
6309413 Dereume et al. Oct 2001 B1
6312454 Stockel et al. Nov 2001 B1
6364903 Tseng et al. Apr 2002 B2
6364904 Smith Apr 2002 B1
6375787 Lukic et al. Apr 2002 B1
6379379 Wang Apr 2002 B1
6383214 Banas et al. May 2002 B1
6398803 Layne et al. Jun 2002 B1
6451047 McCrea et al. Sep 2002 B2
6451052 Burmeister et al. Sep 2002 B1
6488701 Nolting et al. Dec 2002 B1
6497671 Ferrera et al. Dec 2002 B2
6524334 Thompson Feb 2003 B1
6547814 Edwin et al. Apr 2003 B2
6579314 Lombardi et al. Jun 2003 B1
6585760 Fogarty Jul 2003 B1
6673103 Golds et al. Jan 2004 B1
6673105 Chen Jan 2004 B1
6733524 Tseng et al. May 2004 B2
6740115 Lombardi et al. May 2004 B2
6758858 McCrea et al. Jul 2004 B2
6770086 Girton Aug 2004 B1
6770087 Layne et al. Aug 2004 B2
6786920 Shannon et al. Sep 2004 B2
6790225 Shannon et al. Sep 2004 B1
6790226 Edwin et al. Sep 2004 B2
6797217 McCrea et al. Sep 2004 B2
6808533 Goodwin et al. Oct 2004 B1
7060150 Banas et al. Jun 2006 B2
7083640 Lombardi et al. Aug 2006 B2
7288111 Holloway et al. Oct 2007 B1
7306756 Edwin et al. Dec 2007 B2
7462190 Lombardi Dec 2008 B2
7578899 Edwin et al. Aug 2009 B2
7914639 Layne et al. Mar 2011 B2
7939000 Edwin et al. May 2011 B2
8137605 McCrea et al. Mar 2012 B2
8157940 Edwin et al. Apr 2012 B2
8196279 Schlun Jun 2012 B2
8337650 Edwin et al. Dec 2012 B2
20010010012 Edwin et al. Jul 2001 A1
20010021870 Edwin et al. Sep 2001 A1
20010032009 Layne et al. Oct 2001 A1
20010039446 Edwin et al. Nov 2001 A1
20020040237 Lentz et al. Apr 2002 A1
20030004559 Lentz et al. Jan 2003 A1
20030006528 Edwin et al. Jan 2003 A1
20030144725 Lombardi Jul 2003 A1
20030191519 Lombardi et al. Oct 2003 A1
20030201058 Banas et al. Oct 2003 A1
20040024442 Sowinski et al. Feb 2004 A1
20040162603 Golds et al. Aug 2004 A1
20040162604 Sowinski et al. Aug 2004 A1
20040181278 Tseng et al. Sep 2004 A1
20040204757 Lombardi et al. Oct 2004 A1
20040232588 Edwin et al. Nov 2004 A1
20040236400 Edwin et al. Nov 2004 A1
20040236402 Layne et al. Nov 2004 A1
20050055081 Goodwin et al. Mar 2005 A1
20050060020 Jenson Mar 2005 A1
20050096737 Shannon et al. May 2005 A1
20050113909 Shannon et al. May 2005 A1
20050131515 Cully et al. Jun 2005 A1
20050131527 Pathak Jun 2005 A1
20060201609 Edwin et al. Sep 2006 A1
20060229714 Lombardi et al. Oct 2006 A1
20070207186 Scanlon et al. Sep 2007 A1
20090125092 McCrea et al. May 2009 A1
20090294035 Layne et al. Dec 2009 A1
20090311132 Banas et al. Dec 2009 A1
20110126966 Layne et al. Jun 2011 A1
20110196473 McCrea et al. Aug 2011 A1
20120145318 McCrea et al. Jun 2012 A1
20120193018 Banas et al. Aug 2012 A1
Foreign Referenced Citations (66)
Number Date Country
2215027 Sep 1996 CA
03918736 Dec 1990 DE
19524653 Jun 1996 DE
0146794 Jul 1985 EP
0146794 Jul 1985 EP
0221570 May 1987 EP
0221570 May 1987 EP
0335341 Oct 1989 EP
0335341 Oct 1989 EP
0461791 Dec 1991 EP
0461791 Dec 1991 EP
0551179 Jul 1993 EP
0551179 Jul 1993 EP
0603959 Jun 1994 EP
0646365 Apr 1995 EP
0646365 Apr 1995 EP
0648869 Apr 1995 EP
0648869 Apr 1995 EP
0656196 Jun 1995 EP
0656196 Jun 1995 EP
0662307 Jul 1995 EP
0662307 Jul 1995 EP
0667132 Aug 1995 EP
0667132 Aug 1995 EP
0689805 Jan 1996 EP
0689806 Jan 1996 EP
0716835 Jun 1996 EP
0730848 Sep 1996 EP
0734698 Oct 1996 EP
0747022 Dec 1996 EP
0749729 Dec 1996 EP
0749729 Dec 1996 EP
0792627 Sep 1997 EP
0814729 Jan 1998 EP
0893108 Jan 1999 EP
2671482 Jul 1992 FR
1505591 Mar 1978 GB
2281865 Mar 1995 GB
2002510985 Apr 2002 JP
9412136 Jun 1994 WO
9413224 Jun 1994 WO
9424961 Nov 1994 WO
9505132 Feb 1995 WO
9505277 Feb 1995 WO
9505555 Feb 1995 WO
PCTUS9511817 Sep 1995 WO
9600103 Jan 1996 WO
9612517 May 1996 WO
9622745 Aug 1996 WO
9625897 Aug 1996 WO
9628115 Sep 1996 WO
9633066 Oct 1996 WO
9637165 Nov 1996 WO
9640000 Dec 1996 WO
9707751 Mar 1997 WO
9721401 Jun 1997 WO
9721403 Jun 1997 WO
9800090 Jan 1998 WO
9826731 Jun 1998 WO
9831305 Jul 1998 WO
9831305 Jul 1998 WO
9831306 Jul 1998 WO
9838947 Sep 1998 WO
9838947 Sep 1998 WO
0045742 Aug 2000 WO
9510700 Nov 1996 ZA
Non-Patent Literature Citations (58)
Entry
Association for the Advancement of Medical Instrumentation, “Cardiovascular implants—Vascular prostheses” ANSI/AMI, vol. 20. (1994).
Briskman, et al., “A Study of the Crystallinity of Polytetrafluoroethylene by X-Ray Diffraction Analysis and Differential Scanning Calorimetry,” Vysokomol. Soedin , Kratk. Soobshcheniya. vol. 31, No. 7, pp. 539-543. 1989.
Chuter, T., “Bifurcated endovascular graft insertion for abdominal aortic aneurysm” Vascular and Endovascular Surgical Techniques, An Atlas Third Edition, pp. 92-99 (1994).
Cragg, A. and Dake, M., “Persutaneous Femoropopliteal Graft Placement,” Interventional Radiology 187(30: 643-648 (Jun. 1993).
Dietrich, E. and Papazoglou, K. Endoluminal Grafting for Aneurysmal and Occlusive Disease in the Superficial Femoral Artery: Early Experience, J. Endovase Surgery, 2:225-239(1995).
Dorros et al., “Closure of a Popliteal Arteriovenous Fistula Using an Autologous Vein-Covered Palmaz Stent,” J Endovasc Surgery, 2:177-181 (1995).
Heuser et al.,“Endoluminal Grafting for Percutaneous Exclusion in an Aortocoronary Saphenous Vein Graft: The First Clinical Experience,” J Endovasc Surgery, 2:81-88 (1995).
Hu, T., “Characterization of the crystallinity of polytetrafluoroethylene by X-ray and IR spectroscopy, differential scanning calorimetry, viscoelastic spectroscopy and the use of a density gradient tube,” Wear, 82:369-376 (1982).
Khanna et al. “A New Differential Scanning Calorimetry based Approach for the Estimation of Thermal Conductivity of Polymer solids and Melts,” Polymer Engineering and Science, 28(16):1034-1041 (1988).
Khanna, Y.P., “The melting temperature of polytetrafluoroethylene,” Journal of Materials Science Letters, 7(8):817-818 (1988).
Lau et al., “Glass Transition of Poly(tetrafluoroethylene),” Macromolecules 17:1102-1104 (1984).
Lau et al., “The Thermodynamic Properties of Polytetrafluoroethylene,” Journal of Polymer Science: Polymer Physics Edition, 22:379-405 (1984).
Marin et al., “Transluminally placed endovascular stented graft repair for arterial trauma,” The Journal of Vascular Surgery on Compact Disc, 18(6): 11 unnumbered pages (1995).
Marin, M.L. and Veith, F. J., “Endoluminal stented graft aorto-bifemoral reconstruction,” Vascular and Endovascular Surgical Techniques. 3rd Edition, R. M. Greenhalgh ed., W. B. Saunders Company Ltd.: Philadelphia, pp. 100-104 (1994).
Marston et al., “Transbrachial Endovascular Exclusion of an Axillary Artery Pseudoaneurysm with PTFE-Covered Stents,” J. Endovasc Surgery, 2:172-176 (1995).
May et al. “Transluminal placement of a prosthetic graft-stent device for treatment of subclavian artery aneurysm,” Journal of Vascular Surgery, 18(6):10556-1059. 1995.
McClurken et al., “Physical Properties and Test Methods for Expanded Polytetrafluoroethylene (PTFE) Grafts,” American Society for Testing and Materials, 86-14077 pp. 82-93 (1984).
Moore, W., “Transfemoral endovascular repair of abdominal aortic aneurysm using the endovascular graft system device,” Vascular and Endovascular Surgical Techniques. 3rd Edition, R. M. Greenhalgh ed., W. B. Saunders Company Ltd.: Philadelphia, pp. 78-91 (1994).
Palmaz et al. “Uses of balloon expandable stents in combination with PTFE,” Vascular and Endovascular Surgical Techniques, an Atlas, Third Edition, pp. 36-42 (1994).
Palmaz et al., “Use of Stents Covered With Polytetrafluoroethylene in Experimental Abdominal Aortic Aneurysm,” Journal of Vascular and Interventional Radiology, 6(6): 879-885 (1995).
Palmaz et al.,“Physical Properties of Polytetrafluoroethylene Bypass Material After Balloon Dilation,” Journal of Vascular and Interventioanl Radiology, 7(5):657-663 (1996).
Papazoglou et al., “International Congress VIII on Endovascular Interventions” J Endovasc Surg, 2:89-129 (1995).
Parodi, J., “Transfemoral intraluminal graft implantation for abdominal aortic aneurysms,” Annals of Vascular Surgery, 5(6):491-499 (1991).
PCT/US2000/02884 filed Feb. 2, 2000 International Preliminary Examination Report dated Aug. 27, 2002.
PCT/US2000/02884 filed Feb. 2, 2000 International Seach Report dated Jul. 10, 2000.
Shapiro, M. and Levin, D., “Percutaneous Femoropopliteal Graft Placement: Is This the Next Step?” Radiology 187(30: 618-619 (Jun. 1993).
Starkweather, H. W. Jr., “The Density of Amorphous Polytetrafluoroethylene,” Journal of Polymer Science: Polymer Physics Editions, 20:2159-2161 (1982).
U.S. Appl. No. 09/858,035, filed May 15, 2001 Advisory Action dated Oct. 7, 2003.
U.S. Appl. No. 09/858,035, filed May 15, 2001 Final Office Action dated Jul. 25, 2003.
U.S. Appl. No. 09/858,035, filed May 15, 2001 Non-Final Office Action dated Dec. 1, 2003.
U.S. Appl. No. 09/858,035, filed May 15, 2001 Non-Final Office Action dated Oct. 1, 2002.
U.S. Appl. No. 10/242,160, filed Sep. 12, 2002 Non-Final Office Action dated Oct. 27, 2003.
U.S. Appl. No. 10/431,685, filed May 8, 2003 Non-Final Office Action dated Jun. 28, 2005.
U.S. Appl. No. 10/836,492, filed Apr. 30, 2004 Final Office Action dated Nov. 23, 2005.
U.S. Appl. No. 10/836,492, filed Apr. 30, 2004 Non-Final Office Action dated Jun. 8, 2005.
U.S. Appl. No. 10/873,062, filed Jun. 21, 2004 Final Office Action dated Apr. 28, 2008.
U.S. Appl. No. 10/873,062, filed Jun. 21, 2004 Final Office Action dated Jun. 3, 2009.
U.S. Appl. No. 10/873,062, filed Jun. 21, 2004 Non-Final Office Action dated Dec. 18, 2007.
U.S. Appl. No. 10/873,062, filed Jun. 21, 2004 Non-Final Office Action dated Oct. 2, 2008.
U.S. Appl. No. 10/873,514, filed Jun. 21, 2004 Non-Final Office Action dated Jan. 23, 2007.
U.S. Appl. No. 11/429,849, filed May 8, 2006 Final Office Action mailed Mar. 11, 2009.
U.S. Appl. No. 11/429,849, filed May 8, 2006 Final Office Action mailed Oct. 15, 2008.
U.S. Appl. No. 11/447,626, filed Jun. 6, 2006 Final Office Action dated Nov. 14, 2008.
U.S. Appl. No. 11/447,626, filed Jun. 6, 2006 Non-Final Office Action dated Apr. 16, 2008.
U.S. Appl. No. 11/447,626, filed Jun. 6, 2006 Non-Final Office Action dated Sep. 13, 2007.
U.S. Appl. No. 12/272,411, filed Nov. 17, 2008 Final Office Action dated Mar. 9, 2011.
U.S. Appl. No. 12/272,411, filed Nov. 17, 2009 Non-Final Office Action dated Oct. 4, 2010.
U.S. Appl. No. 12/538,361, filed Aug. 10, 2009 Final Office Action dated Sep. 10, 2010.
U.S. Appl. No. 12/538,361, filed Aug. 10, 2009 Non-Final Office Action dated May 26, 2010.
U.S. Appl. No. 12/538,361, filed Aug. 10, 2009 Notice of Allowance dated Dec. 2, 2010.
U.S. Appl. No. 12/546,483, filed Aug. 24, 2009 Final Office Action dated Oct. 20, 2011.
U.S. Appl. No. 12/546,483, filed Aug. 24, 2009 Non-Final Office Action dated Jun. 23, 2011.
U.S. Appl. No. 13/023,403, filed Feb. 8, 2011 Non-Final Office Action dated Apr. 27, 2012.
U.S. Appl. No. 13/023,403, filed Feb. 8, 2011 Non-Final Office Action dated Nov. 23, 2012.
U.S. Appl. No. 13/088,129, filed Apr. 15, 2011 Non-Final Office Action dated Jun. 29, 2011.
U.S. Appl. No. 13/434,472, filed Mar. 29, 2012 Non-Final Office Action dated Jun. 8, 2012.
U.S. Appl. No. 13/434,472, filed Mar. 29, 2012 Notice of Allowance dated Sep. 20, 2012.
Villani, V., “A Study on the Thermal Behaviour and Structural Characteristics of Polytetrafluoroethylene,” Thermochimica Acta, 162:189-193 (1990).
Related Publications (1)
Number Date Country
20130102839 A1 Apr 2013 US
Divisions (2)
Number Date Country
Parent 09855918 May 2001 US
Child 10431685 US
Parent 08999583 Dec 1997 US
Child 09855918 US
Continuations (4)
Number Date Country
Parent 13434472 Mar 2012 US
Child 13715874 US
Parent 12546483 Aug 2009 US
Child 13434472 US
Parent 11429849 May 2006 US
Child 12546483 US
Parent 10431685 May 2003 US
Child 11429849 US
Continuation in Parts (5)
Number Date Country
Parent PCT/US95/16497 Dec 1995 US
Child 08999583 US
Parent 08794871 Feb 1997 US
Child PCT/US95/16497 US
Parent 08833797 Apr 1997 US
Child 08794871 US
Parent 08508033 Jul 1995 US
Child 08833797 US
Parent 08401871 Mar 1995 US
Child 08508033 US